RBC Capital Reiterates Outperform on Zynex, Maintains $15 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has reiterated an Outperform rating on Zynex (NASDAQ:ZYXI) and maintained a $15 price target.
June 14, 2024 | 2:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital has reiterated an Outperform rating on Zynex and maintained a $15 price target, indicating continued confidence in the company's performance.
The reiteration of an Outperform rating and the maintenance of a $15 price target by RBC Capital suggests that the analyst has a positive outlook on Zynex's future performance. This could lead to increased investor confidence and a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100